Estrogenic side effects of androgen deprivation therapy.
Theresa A. Guise(The University of Texas MD Anderson Cancer Center), Matthew R. Smith(Harvard University), Celestia S. Higano(University of British Columbia), Michael S. Cookson(University of Oklahoma Health Sciences Center), Michael G. Oefelein(Genesis HealthCare), James A. Eastham(Memorial Sloan Kettering Cancer Center)
PubMed
January 1, 2007
Cited by 52
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k